$HCAT Cashflow Statement | Understand Stock

$HCAT

$1.57 -$0.06 (3.68%) Close

$HCAT Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities
Net loss
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Stock-based compensation expense
Depreciation and amortization
Investment discount and premium accretion
Impairment of long-lived assets
Non-cash operating lease expense
Provision for expected credit losses
Loss on extinguishment of debt
Amortization of debt discount, issuance costs, and deferred financing costs
Deferred tax provision
Change in fair value of contingent consideration liabilities
Payment of acquisition-related contingent consideration
Impairment of goodwill and intangible assets
Other
Change in operating assets and liabilities:
Accounts receivable, net
Prepaid expenses and other assets
Accounts payable, accrued liabilities, and other liabilities
Deferred revenue
Operating lease liabilities

Net cash provided by (used in) operating activities
Cash flows from investing activities
Proceeds from the sale and maturity of short-term investments
Purchases of short-term investments
Capitalization of internal-use software
Acquisition of businesses, net of cash acquired
Purchases of property and equipment
Purchases of intangible assets
Proceeds from the sale of property and equipment
Net cash provided by (used in) investing activities
Cash flows from financing activities
Proceeds from issuance of long-term debt, net of issuance costs
Payment of deferred financing costs
Proceeds from credit facilities, net of debt issuance costs
Proceeds from the issuance of redeemable convertible preferred stock, net
Payments of deferred offering costs
Repayment of debt
Proceeds from employee stock purchase plan
Proceeds from exercise of stock options
Repurchase of common stock
Payments of acquisition-related consideration
Proceeds from public offerings, net of discounts, commissions, and offering costs
Proceeds from convertible senior notes, net of issuance costs
Purchase of capped calls concurrent with issuance of convertible senior notes
Net cash (used in) provided by financing activities

Effect of exchange rate changes on cash and cash equivalents
Net (decrease) increase in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental disclosures of cash flow information
Cash paid for interest
Cash paid for income taxes, net
Supplemental disclosures of non-cash investing and financing information
Common stock issued in connection with business acquisitions
Operating lease right-of-use assets obtained in exchange for operating lease obligations
Redeemable convertible preferred stock accretion
Stock-based compensation capitalized as internal-use software
Capitalized internal-use software included in accounts payable and accrued liabilities
Purchase of property and equipment included in accounts payable and accrued liabilities
Purchase of intangible assets included in accounts payable and accrued liabilities
Common stock issued for settlement of contingent consideration

Comments